Introduction: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of AHF that benefits from a specific approach. The aim was to determine the prevalence of ATTR-CM among patients hospitalized for AHF.

Methods: A prospective study was conducted on consecutive patients aged 60 or older admitted for acute AHF without cardiogenic shock.

Results: The study included 103 patients, a total of 16 patients (15.5 %) were compatible with ATTR-CM. The ATTR-CM group showed a higher septal wall thickness (18.1 mm vs. 11.8 mm; P = 0.001), lower systolic excursion of the tricuspid annular plane (15 mm vs. 18.3 mm, P = 0.014), and S wave of the right ventricle (8 cm/s vs. 9.2 cm/s P=0.032).

Conclusion: ATTR-CM is an underdiagnosed condition, there are some variables associated with its diagnosis. The coexistence with other comorbidities causing AHF, highlights the importance of considering screening for this cardiomyopathy in adults hospitalized for AHF.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpcardiol.2024.102385DOI Listing

Publication Analysis

Top Keywords

transthyretin amyloid
8
amyloid cardiomyopathy
8
admitted acute
8
attr-cm underdiagnosed
8
patients
5
attr-cm
5
prevalence transthyretin
4
cardiomyopathy patients
4
patients admitted
4
acute heart
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!